Injectable Drug Delivery Resources

  1. Hospital To Home: What It Means For Patients, Providers And Medical Devices 4/16/2025

    Healthcare is shifting homeward. With telehealth, connected devices, and user-friendly design, patients and caregivers now deliver hospital-level care safely and effectively outside clinical settings.

  2. Prefilled Syringes Market Trends: Improving Patient Experience 6/21/2023

    Learn how sterile injectable devices are providing safer and more convenient self-injection delivery, leading to positive patient experiences, better therapy adherence, and improved outcomes.

  3. Biodegradable Polymers For Parenteral Drug Delivery 6/1/2022

    Long-acting, complex drug delivery products, particularly those based on injectable microparticles, nanoparticles, and implants, are among the most attractive parenteral products.

  4. Wearable Injectors: An Alternative To Traditional Intravenous Administration 3/24/2022

    See a quick visual summary of findings from an early feasibility clinical study featuring a 2-5 mL wearable injector with a viscous placebo.

  5. Liposome Vs. Lipid Nanoparticle: What's The Difference? 8/10/2022

    Here, we discuss the differences between nanoparticles and liposomes along with their applications in medicine.

  6. Solubility With Lipid-Based Technologies For Oral & Injectable Formulations 11/7/2022

    Innovative approaches in developing formulations can help to improve a drug's safety and efficacy. Explore the decision for selecting the best-suited technology for formulating a complex molecule.

  7. How To Simplify Your Move From A Vial To A Prefilled Syringe 9/9/2024

    Explore market trends that could impact the lifecycle strategies for your drug product and its packaging. Careful selection of drug packaging can save time and support a successful transition to new formats.

  8. Evaluating The Impact Of Sterilization Methods On Stopper Performances 3/11/2022

    Three studies focus on a product designed to address unmet needs in subcutaneous drug therapies for chronic diseases, including sterilization methods and a Human Factors evaluation.

  9. A Smooth Transition To USP <382> With Established Expertise 3/16/2026

    A new regulatory chapter requires holistic, real‑world testing of injectable systems, mandating full‑system validation with actual drug products and prioritizing patient‑centric performance and safety.

  10. Reliable Components For The Lifecycle Of Your Injectable Drug Product

    As drug products increase in complexity, become more specialized, and trend towards self-administration, it is more important than ever to have a reliable drug closure system.